ESSURE METHOD

Abstract

The widespread use off Bayer's long-term contraceptive Essure is controversial, with women reporting serious side effects in several countries (United States, European countries, and Brazil). This work seeks to understand the international diffusion and introduction of this biomedical artifact in Brazil, based on documentary examination of regulatory bodies, pharmaceutical laboratory websites and notices from hospitals affiliated with the Unified Health System, which aim to enroll women in this procedure. This is a first approach to the topic to investigate the social context of application of this device to users of these health services during the period from 2009 to 2017, when this medical service was available in the country presented as a clinically manageable, safe and harmless device, the The promise of a permanent object to prevent pregnancy without resorting to surgery was sold by Bayer to medical groups as a simple, practical and modern solution to birth control. The reasons that led to the use of the device in Brazil show that the medical community is enthusiastic about the new technology, but long-term clinical monitoring has not been carried out. Especially when victims started demanding that it be removed because it caused too many side effects.